Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Off-target binding of a drug may result in adverse effects that decrease (or complicate) its therapeutic utility (114, 119)”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 85
- Dwivedi, 2015, Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs), Drug Discov. Today, 20, 863, 10.1016/j.drudis.2015.03.004 · DOI · Paper page
- Stuart, 2008, Kinetoplastids: related protozoan pathogens, different diseases., J. Clin. Invest., 118, 1301, 10.1172/JCI33945 · DOI · Paper page
- Barrett, 2012, Management of trypanosomiasis and leishmaniasis, Br. Med. Bull., 104, 175, 10.1093/bmb/lds031 · DOI · Paper page
- Wibowo, 2013, Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition, Proc. Natl. Acad. Sci. U. S. A., 110, 15180, 10.1073/pnas.1308827110 · DOI · Paper page
- Ouellette, 2002, Pterin transport and metabolism in Leishmania and related trypanosomatid parasites., Int. J. Parasitol., 32, 385, 10.1016/S0020-7519(01)00346-0 · doi:10.1016/s0020-7519(01)00346-0
- Anderson, 2011, Antifolate agents: a patent review (2006–2010)., Expert Opin. Ther. Pat., 21, 1293, 10.1517/13543776.2011.587804 · doi:10.1517/13543776.2011.587804
- Nare, 1997, New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity., Parasitology, 114 Suppl, S101, 10.1017/S0031182097001133 · DOI
- Robello, 1997, A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi., Mol. Biochem. Parasitol., 90, 525, 10.1016/S0166-6851(97)00207-7 · DOI
- Vickers, 2011, Folate metabolic pathways in Leishmania, Essays Biochem., 51, 63, 10.1042/bse0510063 · DOI
- Cavazzuti, 2008, Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development., Proc. Natl. Acad. Sci. U. S. A., 105, 1448, 10.1073/pnas.0704384105 · doi:10.1073/pnas.0704384105
- Gibson, 2016, Trypanosoma brucei DHFR-TS revisited: characterisation of a bifunctional and highly unstable recombinant dihydrofolate reductase-thymidylate synthase., PLoS Negl.Trop. Dis., 10, e0004714, 10.1371/journal.pntd.0004714 · doi:10.1371/journal.pntd.0004714
- Meek, 1985, Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica., Biochemistry (Mosc.), 24, 678, 10.1021/bi00324a021 · DOI · Paper page
- Zuccotto, 1999, The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase., Bioorg. Med. Chem. Lett., 9, 1463, 10.1016/S0960-894X(99)00213-9 · doi:10.1016/s0960-894x(99)00213-9
- Cody, 2009, Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes, Biochemistry (Mosc.), 48, 1702, 10.1021/bi801960h · doi:10.1021/bi801960h
- Dawson, 2006, Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate., Mol. Microbiol., 61, 1457, 10.1111/j.1365-2958.2006.05332.x · DOI
- Gilli, 1990, Thermodynamic study of the interaction of methotrexate, its metabolites, and new antifolates with thymidylate synthase: influence of FdUMP., Biochem. Pharmacol., 40, 2241, 10.1016/0006-2952(90)90718-Z · doi:10.1016/0006-2952(90)90718-z
- Corona, 2012, Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors., J. Med. Chem., 55, 8318, 10.1021/jm300563f · DOI
- Borsari, 2016, Profiling of flavonol derivatives for the development of antitrypanosomatidic Drugs., J. Med. Chem., 59, 7598, 10.1021/acs.jmedchem.6b00698 · DOI
- Tulloch, 2010, Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases., J. Med. Chem., 53, 221, 10.1021/jm901059x · doi:10.1021/jm901059x
- Ferrari, 2011, Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase., J. Med. Chem., 54, 211, 10.1021/jm1010572 · DOI
- Mpamhanga, 2009, One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening., J. Med. Chem., 52, 4454, 10.1021/jm900414x · DOI
- Spinks, 2011, Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1., Chemmedchem, 6, 302, 10.1002/cmdc.201000450 · doi:10.1002/cmdc.201000450
- Cunningham, 2002, Parasitic adaptive mechanisms in infection by Leishmania, Exp. Mol. Pathol., 72, 132, 10.1006/exmp.2002.2418 · DOI · Paper page
- Liu, 2012, The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response., Front. Cell. Infect. Microbiol., 2, 83, 10.3389/fcimb.2012.00083 · DOI · Paper page
- de Souza, 2010, Review on Trypanosoma cruzi: host cell interaction., Int. J. Cell Biol., 2010, 10.1155/2010/295394 · DOI · Paper page
- Fiehn, 2010, Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment., Clin. Exp. Rheumatol., 28, S40
- Lu, 2014, Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitis., Clin. Immunol., 150, 64, 10.1016/j.clim.2013.10.010 · DOI
- UniProt Consortium, 2015, UniProt: a hub for protein information., Nucleic Acids Res., 43, D204, 10.1093/nar/gku989 · DOI · Paper page
- Sievers, 2011, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega., Mol. Syst. Biol., 7, 539, 10.1038/msb.2011.75 · DOI · Paper page
- Beitz, 2000, TeXshade: shading and labeling of multiple sequence alignments using LaTeX2e, Bioinformatics, 16, 135, 10.1093/bioinformatics/16.2.135 · DOI · Paper page
- Sussman, 1998, Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules., Acta Crystallogr. D Biol. Crystallogr., 54, 1078, 10.1107/S0907444998009378 · DOI · Paper page
- Chayen, 1992, Microbatch crystallization under oil – a new technique allowing many small-volume crystallization trials, J. Cryst. Growth, 122, 176, 10.1016/0022-0248(92)90241-A · DOI · Paper page
- Leslie, 2006, The integration of macromolecular diffraction data., Acta Crystallogr. D Biol. Crystallogr., 62, 48, 10.1107/S0907444905039107 · DOI · Paper page
- Evans, 2006, Scaling and assessment of data quality., Acta Crystallogr. D Biol. Crystallogr., 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
- Winn, 2011, Overview of the CCP4 suite and current developments., Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
- Vagin, 2010, Molecular replacement with MOLREP., Acta Crystallogr. D Biol. Crystallogr., 66, 22, 10.1107/S0907444909042589 · DOI · Paper page
- Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures., Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI · Paper page
- Emsley, 2004, Coot: model-building tools for molecular graphics., Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Laskowski, 1993, PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944 · DOI · Paper page
- Potterton, 2004, Developments in the CCP4 molecular-graphics project., Acta Crystallogr. D Biol. Crystallogr., 60, 2288, 10.1107/S0907444904023716 · DOI · Paper page
- Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs., Nucleic Acids Res., 25, 3389, 10.1093/nar/25.17.3389 · DOI · Paper page
- Arnold, 2009, The protein model portal., J. Struct. Funct. Genomics, 10, 1, 10.1007/s10969-008-9048-5 · DOI · Paper page
- Hooft, 1996, Errors in protein structures., Nature, 381, 272, 10.1038/381272a0 · DOI · Paper page
- Friesner, 2004, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy., J. Med. Chem., 47, 1739, 10.1021/jm0306430 · DOI · Paper page
- Friesner, 2006, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes., J. Med. Chem., 49, 6177, 10.1021/jm051256o · DOI · Paper page
- Shelley, 2007, Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules., J. Comput. Aided Mol. Des., 21, 681, 10.1007/s10822-007-9133-z · DOI · Paper page
- Greenwood, 2010, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, J. Comput. Aided Mol. Des., 24, 591, 10.1007/s10822-010-9349-1 · DOI · Paper page
- Bas, 2008, Very fast prediction and rationalization of pKa values for protein-ligand complexes., Proteins, 73, 765, 10.1002/prot.22102 · DOI · Paper page
- Jorgensen, 1996, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc., 118, 11225, 10.1021/ja9621760 · DOI · Paper page
- Baroni, 2007, A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application., J. Chem. Inf. Model., 47, 279, 10.1021/ci600253e · DOI · Paper page
- Spyrakis, 2015, A pipeline to enhance ligand virtual screening: integrating molecular dynamics and fingerprints for ligand and proteins., J. Chem. Inf. Model., 55, 2256, 10.1021/acs.jcim.5b00169 · DOI
- Siragusa, 2015, BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity., Proteins, 83, 517, 10.1002/prot.24753 · DOI · Paper page
- Carosati, 2004, Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field, J. Med. Chem., 47, 5114, 10.1021/jm0498349 · doi:10.1021/jm0498349
- Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 · DOI · Paper page
- Halgren, 2007, New method for fast and accurate binding-site identification and analysis., Chem. Biol. Drug Des., 69, 146, 10.1111/j.1747-0285.2007.00483.x · DOI · Paper page
- Halgren, 2009, Identifying and characterizing binding sites and assessing druggability., J. Chem. Inf. Model., 49, 377, 10.1021/ci800324m · DOI · Paper page
- Kokh, 2013, TRAPP: a tool for analysis of transient binding pockets in proteins., J. Chem. Inf. Model., 53, 1235, 10.1021/ci4000294 · DOI
- Gourley, 2001, Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites., Nat. Struct. Biol., 8, 521, 10.1038/88584 · doi:10.1038/88584
- Ong, 2011, Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major., J. Biol. Chem., 286, 10429, 10.1074/jbc.M110.209593 · DOI
- Khalaf, 2014, Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1., J. Med. Chem., 57, 6479, 10.1021/jm500483b · DOI
- Knighton, 1994, Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase., Nat. Struct. Biol., 1, 186, 10.1038/nsb0394-186 · DOI · Paper page
- Senkovich, 2009, Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate, Acta Crystallogr. D Biol. Crystallogr., 65, 704, 10.1107/S090744490901230X · doi:10.1107/s090744490901230x
- Antosiewicz, 2016, Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells., J. Biomol. Struct. Dyn., 1
- Wang, 2016, Substrate channeling between the human dihydrofolate reductase and thymidylate synthase., Protein Sci., 25, 79, 10.1002/pro.2720 · DOI
- Ferrari, 2003, Inhibitor specificity via protein dynamics: insights from the design of antibacterial agents targeted against thymidylate synthase., Chem. Biol., 10, 1183, 10.1016/j.chembiol.2003.11.012 · DOI
- Liang, 1998, Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase., Biochemistry (Mosc.), 37, 12195, 10.1021/bi9803168 · doi:10.1021/bi9803168
- Atreya, 2003, Probing electrostatic channeling in protozoal bifunctional thymidylate synthase-dihydrofolate reductase using site-directed mutagenesis., J. Biol. Chem., 278, 28901, 10.1074/jbc.M212689200 · DOI
- Elcock, 1996, Electrostatic channeling in the bifunctional enzyme dihydrofolate reductase-thymidylate synthase., J. Mol. Biol., 262, 370, 10.1006/jmbi.1996.0520 · doi:10.1006/jmbi.1996.0520
- Garg, 2015, Conservation and role of electrostatics in thymidylate synthase., Sci. Rep., 5, 17356, 10.1038/srep17356 · doi:10.1038/srep17356
- Lee, 1996, Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4., Biochemistry (Mosc.), 35, 7012, 10.1021/bi960028g · DOI
- Pozzi, 2012, The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism., Acta Crystallogr. Sect. D: Biol. Crystallogr., 68, 1232, 10.1107/S0907444912026236 · DOI
- Schormann, 2008, Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function., Proteins, 73, 889, 10.1002/prot.22115 · DOI
- Schormann, 2010, Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase, Bioorg. Med. Chem., 18, 4056, 10.1016/j.bmc.2010.04.020 · doi:10.1016/j.bmc.2010.04.020
- Wilcken, 2011, Addressing methionine in molecular design through directed sulfur-halogen bonds, J. Chem. Theory Comput., 7, 2307, 10.1021/ct200245e · DOI
- Imai, 2007, Propensities of polar and aromatic amino acids in noncanonical interactions: nonbonded contacts analysis of protein-ligand complexes in crystal structures, J. Med. Chem., 50, 1189, 10.1021/jm061038a · doi:10.1021/jm061038a
- Wallnoefer, 2010, Dispersion dominated halogen-pi interactions: energies and locations of minima, Phys. Chem. Chem. Phys., 12, 14941, 10.1039/c0cp00607f · DOI
- Henrich, 2008, On the use of PIPSA to guide target-selective drug design., Chemmedchem, 3, 413, 10.1002/cmdc.200700154 · doi:10.1002/cmdc.200700154
- Arrebola, 1994, Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells., J. Biol. Chem., 269, 10590, 10.1016/S0021-9258(17)34100-5 · doi:10.1016/s0021-9258(17)34100-5
- Iwai, 1981, Purification and properties of dihydrofolate reductase from Crithidia fasciculata, Agric. Biol. Chem., 45, 113
- Jarabak, 1971, A soluble dihydrofolate reductase from human placenta: purification and properties., Arch. Biochem. Biophys., 142, 417, 10.1016/0003-9861(71)90505-4 · DOI
- Atreya, 2003, A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase, J. Biol. Chem., 278, 14092, 10.1074/jbc.M212690200 · doi:10.1074/jbc.m212690200
- Finn, 2016, The Pfam protein families database: towards a more sustainable future., Nucleic Acids Res., 44, D279, 10.1093/nar/gkv1344 · DOI · Paper page
- Montgomery, 1979, Analogues of methotrexate, J. Med. Chem., 22, 862, 10.1021/jm00193a021 · doi:10.1021/jm00193a021
- Piper, 1982, 10-Propargylaminopterin and alkyl homologues of methotrexate as inhibitors of folate metabolism, J. Med. Chem., 25, 877, 10.1021/jm00349a024 · doi:10.1021/jm00349a024
- Synold, 1996, Role of folylpolygutamate synthetase (FPGS) in antifolate chemotherapy; a biochemical and clinical update., Leuk. Lymphoma, 21, 9, 10.3109/10428199609067573 · doi:10.3109/10428199609067573
Cited by
Allostery in Its Many Disguises: From Theory to Applications
Wodak, S. J., Paci, E., Dokholyan, N. V., Berezovsky, I. N., Horovitz, A., Li, J., Hilser, V. J., Bahar, I., Karanicolas, J., Stock, G., et al. (2019) · Structure · doi:10.1016/j.str.2019.01.003 · Cited by 404
“Panecka-Hofman and Wade reported preliminary results on the dynamic allosteric coupling between distant residues of pteridine reductase 1, a folate pathway enzyme unique to trypanosomatid parasites (Panecka-Hofman et al., 2017) (Figure S7).”
BackgroundSelf-citationSmith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Metadata
- Authors
- Panecka-Hofman, J., Pöhner, I., Spyrakis, F., Zeppelin, T., Di Pisa, F., Dello Iacono, L., Bonucci, A., Quotadamo, A., Venturelli, A., Mangani, S., Costi, M. P., & Wade, R. C.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 1861
- Issue
- 12
- Pages
- 3215-3230
- ISSN
- 0304-4165
- Cited by
- 24
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.